{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:22:55Z","timestamp":1780428175057,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84439-4","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:46:50Z","timestamp":1735876010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Detection of exon2-MED12 mutations in uterine leiomyomas from Syrian patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Lina","family":"Albitar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Al-Chatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"84439_CR1","doi-asserted-by":"crossref","unstructured":"Cheng, L. C. et al. Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Front. Med. (Lausanne) 9, 1003605 (2022).","DOI":"10.3389\/fmed.2022.1003605"},{"key":"84439_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1097\/AOG.0000000000002785","volume":"132","author":"SK Laughlin-Tommaso","year":"2018","unstructured":"Laughlin-Tommaso, S. K. & Stewart, E. A. Moving toward individualized medicine for uterine leiomyomas. Obstet. Gynecol. 132, 961\u2013971 (2018).","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"84439_CR3","first-page":"16","volume":"37","author":"EA Stewart","year":"2022","unstructured":"Stewart, E. A. & Nowak, R. A. Uterine fibroids: Hiding in plain sight. Physiology (Bethesda) 37(1), 16\u201327 (2022).","journal-title":"Physiology (Bethesda)"},{"key":"84439_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/his.12039","volume":"62","author":"A Matsubara","year":"2013","unstructured":"Matsubara, A. et al. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology 62, 657\u2013661 (2013).","journal-title":"Histopathology"},{"issue":"5","key":"84439_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1530\/REP-16-0216","volume":"152","author":"SJ Holdsworth-Carson","year":"2016","unstructured":"Holdsworth-Carson, S. J. et al. Differences in the cellular composition of small versus large uterine fibroids. Reproduction 152(5), 467\u2013480 (2016).","journal-title":"Reproduction"},{"issue":"6","key":"84439_CR6","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.3390\/ijms24065752","volume":"24","author":"AS Koltsova","year":"2023","unstructured":"Koltsova, A. S., Efimova, O. A. & Pendina, A. A. A view on uterine leiomyoma genesis through the prism of genetic, epigenetic and cellular heterogeneity. Int. J. Mol. Sci. 24(6), 5752 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"84439_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine, M. et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. P. N. A. S. 113, 1315\u20131320 (2016).","journal-title":"P. N. A. S."},{"key":"84439_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-017-0672-1","volume":"16","author":"N M\u00e4kinen","year":"2017","unstructured":"M\u00e4kinen, N., K\u00e4mpj\u00e4rvi, K., B\u00fctzow, R. & Vahteristo, P. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol. Cancer. 16, 10 (2017).","journal-title":"Mol. Cancer."},{"key":"84439_CR9","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.3390\/ijms22168483","volume":"22","author":"A Machado-Lopez","year":"2021","unstructured":"Machado-Lopez, A., Sim\u00f3n, C. & Mas, A. Molecular and cellular insights into the development of uterine fibroids. Int. J. Mol. Sci. 22, 8483 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"84439_CR10","doi-asserted-by":"publisher","DOI":"10.1530\/JME-23-0039","volume":"71","author":"H Ishikawa","year":"2023","unstructured":"Ishikawa, H. et al. Rising stars: Role of MED12 mutation in the pathogenesis of uterine fibroids. J. Mol. Endocrinol. 71(4), e230039 (2023).","journal-title":"J. Mol. Endocrinol."},{"key":"84439_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen, N. et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252\u2013255 (2011).","journal-title":"Science"},{"key":"84439_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.18632\/oncotarget.370","volume":"2","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen, N. et al. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2, 966\u2013969 (2011).","journal-title":"Oncotarget."},{"key":"84439_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire, M. M. et al. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PloS one. 7, e33251 (2012).","journal-title":"PloS one."},{"key":"84439_CR14","doi-asserted-by":"publisher","first-page":"E1044","DOI":"10.1002\/ijc.27610","volume":"131","author":"EM Je","year":"2012","unstructured":"Je, E. M., Kim, M. R., Min, K. O., Yoo, N. J. & Lee, S. H. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int. J. Cancer. 131, E1044\u2013E1047 (2012).","journal-title":"Int. J. Cancer."},{"issue":"3","key":"84439_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine, M., M\u00e4kinen, N., Heinonen, H. R., Aaltonen, L. A. & Vahteristo, P. Genomics of uterine leiomyomas: Insights from high-throughput sequencing. Fertil. Steril. 102(3), 621\u2013629 (2014).","journal-title":"Fertil. Steril."},{"key":"84439_CR16","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3892\/ol.2015.3118","volume":"9","author":"J Ye","year":"2015","unstructured":"Ye, J. et al. MED12 mutation in patients with hysteromyoma. Oncol. Lett. 9, 2771\u20132774 (2015).","journal-title":"Oncol. Lett."},{"key":"84439_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/ol.2017.6120","volume":"14","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma. Oncol. Lett. 14, 47\u201354 (2017).","journal-title":"Oncol. Lett."},{"issue":"2","key":"84439_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7150\/ijms.21856","volume":"15","author":"M Lee","year":"2018","unstructured":"Lee, M. et al. Analysis of MED12 mutation in multiple uterine leiomyomas in South Korean patients. Int. J. Med. Sci. 15(2), 124\u2013128 (2018).","journal-title":"Int. J. Med. Sci."},{"key":"84439_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tibs.2010.02.004","volume":"35","author":"DJ Taatjes","year":"2010","unstructured":"Taatjes, D. J. The human mediator complex: A versatile, genome-wide regulator of transcription. Trends Biochem. Sci. 35, 315\u2013322 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"84439_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005850","volume":"12","author":"N M\u00e4kinen","year":"2016","unstructured":"M\u00e4kinen, N. et al. Exome sequencing of uterine Leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12. PLoS Genet. 12, e1005850 (2016).","journal-title":"PLoS Genet."},{"key":"84439_CR21","doi-asserted-by":"crossref","unstructured":"Heinonen,\u00a0H. R. et al. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci. Rep. 7, 1015 (2017)","DOI":"10.1038\/s41598-017-01199-0"},{"issue":"5","key":"84439_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/cncr.32672","volume":"126","author":"S Zhang","year":"2020","unstructured":"Zhang, S., O\u2019Regan, R. & Xu, W. The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics. Cancer. 126(5), 939\u2013948 (2020).","journal-title":"Cancer."},{"issue":"8","key":"84439_CR23","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal, P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J. Clin. Invest. 125(8), 3280\u20133284 (2015).","journal-title":"J. Clin. Invest."},{"issue":"3","key":"84439_CR24","first-page":"592","volume":"158","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy, A. et al. Silencing Med12 gene reduces proliferation of human leiomyoma cells mediated via Wnt\/\u03b2-catenin signaling pathway. Endocrine 158(3), 592\u2013603 (2017).","journal-title":"Endocrine"},{"key":"84439_CR25","first-page":"1300","volume":"21","author":"N Makinen","year":"2013","unstructured":"Makinen, N. et al. MED12 exon 2 mutations in histopathological uterine leiomyoma variants. E. J. H. G. 21, 1300\u20131303 (2013).","journal-title":"E. J. H. G."},{"issue":"13","key":"84439_CR26","first-page":"4870","volume":"293","author":"MJ Park","year":"2018","unstructured":"Park, M. J. et al. Oncogenic exon 2 mutations in mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8\/19. J. B. C. 293(13), 4870\u20134882 (2018).","journal-title":"J. B. C."},{"issue":"1","key":"84439_CR27","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/s41467-023-39684-y","volume":"14","author":"K Buyukcelebi","year":"2023","unstructured":"Buyukcelebi, K. et al. Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization. Nat. Commun. 14(1), 4057 (2023).","journal-title":"Nat. Commun."},{"issue":"7","key":"84439_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/hmg\/ddac217","volume":"32","author":"\u00c5 Kolterud","year":"2023","unstructured":"Kolterud, \u00c5. et al. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. Hum. Mol. Genet. 32(7), 1063\u20131071 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"84439_CR29","unstructured":"Albitar, L., Al-Chatty, E. & Ahmad, F. Optimizing tissue fixation conditions for molecular study of the MED12 gene in FFPE uterine leiomyoma tissues. Damas. Uni. J. Med. Sci. (in press)."},{"issue":"7","key":"84439_CR30","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski, D. N. et al. MED12 mutations in uterine fibroids\u2013Their relationship to cytogenetic subgroups. Int. J. Cancer. 131(7), 1528\u20131536 (2012).","journal-title":"Int. J. Cancer."},{"key":"84439_CR31","unstructured":"Keneme, B. et al. Prediction of the structure and mutations instability of the Med12 exon2 gene in uterine fibroids in Senegalese women. I. J. G. G. 7(3), 80\u201387 (2019)."},{"key":"84439_CR32","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1093\/nar\/gkn349","volume":"36","author":"HM Bourbon","year":"2008","unstructured":"Bourbon, H. M. Comparative genomics supports a deep evolutionary origin for the large, four module transcriptional mediator complex. Nucleic Acids Res. 36, 3993\u20134008 (2008).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"84439_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","volume":"7","author":"M Turunen","year":"2014","unstructured":"Turunen, M. et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep. 7(3), 654\u2013660 (2014).","journal-title":"Cell Rep."},{"key":"84439_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fgene.2018.00552","volume":"9","author":"GMA Ajabnoor","year":"2018","unstructured":"Ajabnoor, G. M. A. et al. Expanded somatic mutation spectrum of MED12 gene in uterine leiomyomas of Saudi Arabian women. Front. Genet. 9, 552 (2018).","journal-title":"Front. Genet."},{"issue":"10","key":"84439_CR35","first-page":"11","volume":"38","author":"B Keneme","year":"2023","unstructured":"Keneme, B. & Sembene, M. Prediction by in silico tools of non-synonymous single nucleotide polymorphisms (nsSNP) and 3-d protein structure prediction in the female MED12 gene associated with uterine leiomyomas. A. R. R. B. 38(10), 11\u201323 (2023).","journal-title":"A. R. R. B."},{"issue":"2","key":"84439_CR36","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s13277-015-3943-8","volume":"37","author":"S Sadeghi","year":"2016","unstructured":"Sadeghi, S. et al. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Tumor Biol. 37(2), 1567\u20131571 (2016).","journal-title":"Tumor Biol."},{"key":"84439_CR37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/humu.22612","volume":"35","author":"K K\u00e4mpj\u00e4rvi","year":"2014","unstructured":"K\u00e4mpj\u00e4rvi, K. et al. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum. Mutat. 35, 1136\u20131141 (2014).","journal-title":"Hum. Mutat."},{"key":"84439_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41389-022-00425-3","volume":"11","author":"M Mehine","year":"2022","unstructured":"Mehine, M. et al. A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase. Oncogenesis 11, 52 (2022).","journal-title":"Oncogenesis"},{"issue":"3","key":"84439_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ajhg.2023.01.009","volume":"110","author":"N V\u00e4lim\u00e4ki","year":"2023","unstructured":"V\u00e4lim\u00e4ki, N. et al. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas. Am. J. Hum. Genet. 110(3), 460\u2013474 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"84439_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","volume":"87","author":"WH Parker","year":"2007","unstructured":"Parker, W. H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril. 87, 725\u2013736 (2007).","journal-title":"Fertil. Steril."},{"key":"84439_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","volume":"22","author":"S Okolo","year":"2008","unstructured":"Okolo, S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 571\u2013588 (2008).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"84439_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz, J. M., Cooper, D. N., Schuelke, M. & Seelow, D. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat. Methods 11(4), 361\u2013362 (2014).","journal-title":"Nat. Methods"},{"key":"84439_CR43","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","volume":"102","author":"HR Heinonen","year":"2014","unstructured":"Heinonen, H. R. et al. MED12 mutation frequency in unselected sporadic uterine leiomyomas. Fertil. Steril. 102, 1137\u20131142 (2014).","journal-title":"Fertil. Steril."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84439-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84439-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T03:05:59Z","timestamp":1735959959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84439-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84439-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}